NO20021306D0 - Formulations for parenteral use of estramustine phosphate with improved pharmacological properties - Google Patents

Formulations for parenteral use of estramustine phosphate with improved pharmacological properties

Info

Publication number
NO20021306D0
NO20021306D0 NO20021306A NO20021306A NO20021306D0 NO 20021306 D0 NO20021306 D0 NO 20021306D0 NO 20021306 A NO20021306 A NO 20021306A NO 20021306 A NO20021306 A NO 20021306A NO 20021306 D0 NO20021306 D0 NO 20021306D0
Authority
NO
Norway
Prior art keywords
formulations
pharmacological properties
parenteral use
estramustine phosphate
improved pharmacological
Prior art date
Application number
NO20021306A
Other languages
Norwegian (no)
Other versions
NO20021306L (en
Inventor
Lorena Muggetti
Paolo Colombo
Alessandro Martini
Giovanni Buzzi
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of NO20021306D0 publication Critical patent/NO20021306D0/en
Publication of NO20021306L publication Critical patent/NO20021306L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20021306A 1999-09-16 2002-03-15 Formulations for parenteral use of estramustine phosphate with improved formacological properties NO20021306L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9921954.5A GB9921954D0 (en) 1999-09-16 1999-09-16 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
PCT/EP2000/007679 WO2001019338A1 (en) 1999-09-16 2000-08-03 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties

Publications (2)

Publication Number Publication Date
NO20021306D0 true NO20021306D0 (en) 2002-03-15
NO20021306L NO20021306L (en) 2002-04-24

Family

ID=10861066

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021306A NO20021306L (en) 1999-09-16 2002-03-15 Formulations for parenteral use of estramustine phosphate with improved formacological properties

Country Status (20)

Country Link
EP (1) EP1212040A1 (en)
JP (1) JP2003509355A (en)
KR (1) KR20020059405A (en)
CN (1) CN1177583C (en)
AU (1) AU777763B2 (en)
BR (1) BR0014063A (en)
CA (1) CA2385063A1 (en)
CZ (1) CZ2002943A3 (en)
EA (1) EA005308B1 (en)
GB (1) GB9921954D0 (en)
HK (1) HK1047227A1 (en)
HU (1) HUP0202621A2 (en)
IL (1) IL148409A0 (en)
MX (1) MXPA02002859A (en)
NO (1) NO20021306L (en)
NZ (1) NZ517631A (en)
PL (1) PL353954A1 (en)
SK (1) SK3452002A3 (en)
WO (1) WO2001019338A1 (en)
ZA (1) ZA200201743B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658913B2 (en) 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
US9215679B2 (en) 2010-09-21 2015-12-15 Telefonaktiebolaget L M Ericsson (Publ) Air-interface timing synchronization sharing
WO2019094819A2 (en) * 2017-11-09 2019-05-16 Abon Pharmaceuticals, Llc Intravenous delivery systems for chemotherapy drugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59108800A (en) * 1982-12-13 1984-06-23 Japan Atom Energy Res Inst Fine particle having guided missile action and slow-releasing function of carcinostatic agent
KR0166088B1 (en) * 1990-01-23 1999-01-15 . Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5602112A (en) * 1992-06-19 1997-02-11 Supergen, Inc. Pharmaceutical formulation
GB9419153D0 (en) * 1994-09-22 1994-11-09 Erba Carlo Spa Estramustine formulations with improved pharmaceutical properties
US20020039594A1 (en) * 1997-05-13 2002-04-04 Evan C. Unger Solid porous matrices and methods of making and using the same

Also Published As

Publication number Publication date
CN1374858A (en) 2002-10-16
NZ517631A (en) 2004-01-30
GB9921954D0 (en) 1999-11-17
NO20021306L (en) 2002-04-24
KR20020059405A (en) 2002-07-12
WO2001019338A1 (en) 2001-03-22
ZA200201743B (en) 2003-05-28
AU6836300A (en) 2001-04-17
BR0014063A (en) 2004-06-29
CA2385063A1 (en) 2001-03-22
HK1047227A1 (en) 2003-02-14
IL148409A0 (en) 2002-09-12
EA200200369A1 (en) 2002-08-29
CZ2002943A3 (en) 2002-08-14
JP2003509355A (en) 2003-03-11
EA005308B1 (en) 2004-12-30
EP1212040A1 (en) 2002-06-12
PL353954A1 (en) 2003-12-15
AU777763B2 (en) 2004-10-28
MXPA02002859A (en) 2003-07-21
SK3452002A3 (en) 2002-08-06
CN1177583C (en) 2004-12-01
HUP0202621A2 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
TW427444U (en) Improved structure of expansion screw
PL352296A1 (en) Crystalline derivatives of 1-methylocarbapeneme
NO20024321D0 (en) Process for the preparation of crystalline form I of cabergoline
NO20016151D0 (en) Preparation of substituted piperidin-4-ones
NO20021306D0 (en) Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
EG22480A (en) Manufacture of centrifuged pipes
NO20020059L (en) Process for the preparation of dibenzothiazepine derivatives
IL149534A0 (en) Preparation of 3-substituted-4-arylquinolin-2-one derivatives
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
GB9921958D0 (en) Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins
NO20014383L (en) Process for Preparation of Cyclo- (Asp-DPhe-NMeVal-Arg-Gly)
NO20014845D0 (en) Use of arylalkanoylpyridazines
NO20016030D0 (en) Derivatives of 4'-demycarosyl-8a-aza-8a-homothylosin
NO20020328D0 (en) Process for the preparation of 4-cyano-2-aminomethylthiazole
NO20013044D0 (en) Process for the preparation of NG-substituted deazadenosine derivatives
NO20005818D0 (en) Improved process for the preparation of pharmaceutically valuable norbenzomorphan derivatives
NO20020327D0 (en) Process for the preparation of 2-aminomethyl-4-cyano-thiazole
NO20021234D0 (en) Use of thienopyrimidines
NO20022671D0 (en) Process for the preparation of thienopyrimidines
AU2954000A (en) The pharmacological use of certain cystine derivatives
NO20013453D0 (en) Process for the preparation of salts of cyanobenzylamines
IL146505A0 (en) Methods for the preparation of tetrahydroisoquinolinephenol derivatives
TW416457U (en) Modified structure of trowel
TW395176U (en) Structure of designed article

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application